Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Molecular Diagnostic Techniques | 4 | 2020 | 74 | 1.170 |
Why?
|
| Microbiological Techniques | 5 | 2019 | 25 | 0.910 |
Why?
|
| Legionellosis | 1 | 2024 | 6 | 0.860 |
Why?
|
| Legionella | 1 | 2024 | 16 | 0.860 |
Why?
|
| Endocarditis, Bacterial | 1 | 2024 | 38 | 0.840 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 341 | 0.810 |
Why?
|
| Clinical Laboratory Techniques | 3 | 2020 | 79 | 0.800 |
Why?
|
| Bacteremia | 2 | 2014 | 110 | 0.780 |
Why?
|
| Immunoglobulin G | 4 | 2023 | 480 | 0.780 |
Why?
|
| Bacteria | 4 | 2017 | 546 | 0.780 |
Why?
|
| Betacoronavirus | 3 | 2020 | 286 | 0.760 |
Why?
|
| Antibodies, Viral | 4 | 2022 | 341 | 0.750 |
Why?
|
| Mycoplasma genitalium | 1 | 2022 | 3 | 0.730 |
Why?
|
| Mycoplasma Infections | 1 | 2022 | 9 | 0.730 |
Why?
|
| Gonorrhea | 1 | 2022 | 24 | 0.710 |
Why?
|
| Chlamydia Infections | 1 | 2022 | 30 | 0.710 |
Why?
|
| Mycobacterium chelonae | 1 | 2021 | 4 | 0.680 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2021 | 25 | 0.660 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2022 | 114 | 0.620 |
Why?
|
| Immunoglobulin A | 1 | 2020 | 94 | 0.610 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 373 | 0.590 |
Why?
|
| Bacteriological Techniques | 2 | 2019 | 39 | 0.570 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2021 | 214 | 0.560 |
Why?
|
| Blood | 2 | 2017 | 68 | 0.560 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 337 | 0.550 |
Why?
|
| Sexual and Gender Minorities | 1 | 2022 | 262 | 0.540 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2014 | 83 | 0.540 |
Why?
|
| Influenza, Human | 2 | 2018 | 357 | 0.520 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2017 | 26 | 0.520 |
Why?
|
| Sensitivity and Specificity | 10 | 2024 | 1945 | 0.510 |
Why?
|
| Actinomyces | 1 | 2015 | 4 | 0.450 |
Why?
|
| Earache | 1 | 2015 | 4 | 0.450 |
Why?
|
| Actinomycosis | 1 | 2015 | 12 | 0.450 |
Why?
|
| Maxillary Sinusitis | 1 | 2015 | 15 | 0.450 |
Why?
|
| Neisseria meningitidis, Serogroup Y | 1 | 2014 | 2 | 0.440 |
Why?
|
| Arthritis, Infectious | 1 | 2014 | 19 | 0.430 |
Why?
|
| Specimen Handling | 1 | 2014 | 113 | 0.400 |
Why?
|
| Knee Joint | 1 | 2014 | 179 | 0.400 |
Why?
|
| Adenoviridae Infections | 1 | 2012 | 16 | 0.370 |
Why?
|
| Spike Glycoprotein, Coronavirus | 2 | 2022 | 67 | 0.330 |
Why?
|
| Serologic Tests | 2 | 2020 | 42 | 0.320 |
Why?
|
| Immunocompromised Host | 3 | 2021 | 139 | 0.300 |
Why?
|
| Fatal Outcome | 2 | 2024 | 295 | 0.290 |
Why?
|
| Nasopharynx | 2 | 2020 | 51 | 0.290 |
Why?
|
| Immunoglobulin M | 3 | 2024 | 154 | 0.280 |
Why?
|
| Humans | 32 | 2024 | 98370 | 0.280 |
Why?
|
| Antibodies, Protozoan | 2 | 2024 | 47 | 0.250 |
Why?
|
| Toxoplasma | 2 | 2024 | 115 | 0.230 |
Why?
|
| Respiratory Tract Infections | 2 | 2018 | 112 | 0.230 |
Why?
|
| Toxoplasmosis, Congenital | 1 | 2024 | 47 | 0.200 |
Why?
|
| Chromatography, Affinity | 1 | 2023 | 73 | 0.200 |
Why?
|
| Blood Gas Analysis | 2 | 2020 | 35 | 0.200 |
Why?
|
| Automation, Laboratory | 2 | 2020 | 12 | 0.200 |
Why?
|
| Microscopy | 2 | 2014 | 92 | 0.190 |
Why?
|
| Prospective Studies | 3 | 2023 | 4818 | 0.190 |
Why?
|
| Toxoplasmosis | 1 | 2023 | 69 | 0.190 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2020 | 41 | 0.190 |
Why?
|
| Chlamydia trachomatis | 1 | 2022 | 15 | 0.180 |
Why?
|
| Neisseria gonorrhoeae | 1 | 2022 | 18 | 0.180 |
Why?
|
| Helicobacter Infections | 1 | 2021 | 36 | 0.170 |
Why?
|
| Helicobacter pylori | 1 | 2021 | 36 | 0.170 |
Why?
|
| Gastritis | 1 | 2021 | 38 | 0.160 |
Why?
|
| Adult | 8 | 2023 | 29587 | 0.160 |
Why?
|
| Syringes | 1 | 2020 | 15 | 0.160 |
Why?
|
| Plasma Cells | 1 | 2021 | 91 | 0.160 |
Why?
|
| Blood Specimen Collection | 1 | 2020 | 29 | 0.160 |
Why?
|
| Stomach | 1 | 2021 | 112 | 0.160 |
Why?
|
| Biopsy | 2 | 2021 | 1225 | 0.160 |
Why?
|
| Time Factors | 5 | 2017 | 5577 | 0.160 |
Why?
|
| Child, Preschool | 3 | 2021 | 4042 | 0.150 |
Why?
|
| Diagnostic Errors | 2 | 2018 | 161 | 0.150 |
Why?
|
| Male | 12 | 2023 | 47263 | 0.150 |
Why?
|
| Pathology, Surgical | 1 | 2019 | 13 | 0.150 |
Why?
|
| Nasal Mucosa | 1 | 2020 | 194 | 0.150 |
Why?
|
| Cross Reactions | 4 | 2021 | 116 | 0.150 |
Why?
|
| Lung Transplantation | 1 | 2024 | 390 | 0.150 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2017 | 151 | 0.150 |
Why?
|
| Chicago | 3 | 2020 | 1519 | 0.150 |
Why?
|
| Pharyngitis | 1 | 2019 | 18 | 0.150 |
Why?
|
| Streptococcus pyogenes | 1 | 2019 | 38 | 0.150 |
Why?
|
| Autopsy | 1 | 2019 | 131 | 0.150 |
Why?
|
| Catheters | 1 | 2020 | 109 | 0.150 |
Why?
|
| Streptococcal Infections | 1 | 2019 | 58 | 0.150 |
Why?
|
| Bordetella Infections | 1 | 2018 | 5 | 0.140 |
Why?
|
| Homosexuality, Male | 1 | 2022 | 342 | 0.140 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2018 | 22 | 0.140 |
Why?
|
| Clostridium Infections | 1 | 2020 | 132 | 0.140 |
Why?
|
| Antimicrobial Stewardship | 1 | 2018 | 27 | 0.140 |
Why?
|
| Drug Utilization | 1 | 2018 | 65 | 0.130 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2018 | 90 | 0.130 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2017 | 11 | 0.130 |
Why?
|
| Influenza B virus | 1 | 2017 | 36 | 0.130 |
Why?
|
| Lymphotoxin alpha1, beta2 Heterotrimer | 1 | 2017 | 4 | 0.130 |
Why?
|
| Lymphotoxin beta Receptor | 1 | 2017 | 25 | 0.130 |
Why?
|
| Fungi | 1 | 2017 | 70 | 0.130 |
Why?
|
| Workflow | 1 | 2017 | 86 | 0.130 |
Why?
|
| Pandemics | 2 | 2020 | 914 | 0.130 |
Why?
|
| False Positive Reactions | 3 | 2024 | 214 | 0.120 |
Why?
|
| Influenza A virus | 1 | 2017 | 177 | 0.120 |
Why?
|
| Influenza Vaccines | 1 | 2018 | 176 | 0.120 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 301 | 0.120 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 2017 | 119 | 0.120 |
Why?
|
| Seminal Vesicles | 1 | 2016 | 40 | 0.120 |
Why?
|
| Intensive Care Units | 1 | 2020 | 474 | 0.120 |
Why?
|
| Middle Aged | 8 | 2023 | 29532 | 0.110 |
Why?
|
| Maxillary Sinus | 1 | 2015 | 21 | 0.110 |
Why?
|
| Cytomegalovirus Infections | 1 | 2016 | 116 | 0.110 |
Why?
|
| Lymphocytes | 1 | 2017 | 461 | 0.110 |
Why?
|
| Oseltamivir | 1 | 2015 | 9 | 0.110 |
Why?
|
| Histocytochemistry | 2 | 2012 | 122 | 0.110 |
Why?
|
| Oxygen | 1 | 2020 | 773 | 0.110 |
Why?
|
| Viruses | 1 | 2015 | 64 | 0.100 |
Why?
|
| Virus Diseases | 1 | 2015 | 83 | 0.100 |
Why?
|
| Yeasts | 1 | 2013 | 50 | 0.100 |
Why?
|
| Female | 10 | 2024 | 51761 | 0.100 |
Why?
|
| Mycoses | 1 | 2013 | 46 | 0.100 |
Why?
|
| Sepsis | 1 | 2017 | 402 | 0.100 |
Why?
|
| Immunity, Innate | 1 | 2017 | 482 | 0.100 |
Why?
|
| Aged, 80 and over | 3 | 2021 | 7418 | 0.090 |
Why?
|
| Temperature | 1 | 2014 | 442 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 880 | 0.090 |
Why?
|
| Family Health | 1 | 2012 | 157 | 0.090 |
Why?
|
| Child | 4 | 2021 | 7750 | 0.090 |
Why?
|
| Young Adult | 3 | 2023 | 7568 | 0.090 |
Why?
|
| Bacterial Infections | 1 | 2013 | 184 | 0.090 |
Why?
|
| Antiviral Agents | 1 | 2015 | 369 | 0.090 |
Why?
|
| Adolescent | 3 | 2023 | 10140 | 0.090 |
Why?
|
| Aged | 6 | 2023 | 21844 | 0.090 |
Why?
|
| DNA, Bacterial | 3 | 2019 | 236 | 0.090 |
Why?
|
| Microbiota | 1 | 2017 | 472 | 0.080 |
Why?
|
| Granuloma, Respiratory Tract | 1 | 2011 | 4 | 0.080 |
Why?
|
| Pseudomonas | 1 | 2011 | 48 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 894 | 0.080 |
Why?
|
| Infant | 1 | 2017 | 3361 | 0.080 |
Why?
|
| Pseudomonas Infections | 1 | 2011 | 95 | 0.080 |
Why?
|
| Antigens, Viral | 2 | 2021 | 123 | 0.070 |
Why?
|
| Tinea Capitis | 1 | 2009 | 2 | 0.070 |
Why?
|
| Lung | 2 | 2012 | 1408 | 0.070 |
Why?
|
| Microsporum | 1 | 2007 | 1 | 0.060 |
Why?
|
| Tinea Favosa | 1 | 2007 | 1 | 0.060 |
Why?
|
| Reagent Kits, Diagnostic | 2 | 2019 | 39 | 0.060 |
Why?
|
| Multiplex Polymerase Chain Reaction | 2 | 2018 | 38 | 0.060 |
Why?
|
| Pregnancy | 2 | 2024 | 3269 | 0.060 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 1785 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2021 | 1817 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2021 | 2792 | 0.050 |
Why?
|
| Prenatal Diagnosis | 1 | 2024 | 107 | 0.050 |
Why?
|
| Gastroscopy | 1 | 2021 | 25 | 0.040 |
Why?
|
| Interferon Regulatory Factors | 1 | 2021 | 76 | 0.040 |
Why?
|
| Immunity, Humoral | 1 | 2021 | 76 | 0.040 |
Why?
|
| Epitopes | 1 | 2021 | 259 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2021 | 264 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2021 | 175 | 0.040 |
Why?
|
| Frozen Sections | 1 | 2019 | 51 | 0.040 |
Why?
|
| Pharynx | 1 | 2019 | 43 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2020 | 489 | 0.040 |
Why?
|
| Point-of-Care Testing | 1 | 2019 | 29 | 0.040 |
Why?
|
| Bordetella bronchiseptica | 1 | 2018 | 6 | 0.040 |
Why?
|
| Bordetella pertussis | 1 | 2018 | 17 | 0.040 |
Why?
|
| Antigens, Bacterial | 1 | 2019 | 135 | 0.040 |
Why?
|
| Eggs | 1 | 2018 | 14 | 0.040 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 1 | 2018 | 12 | 0.030 |
Why?
|
| Ferrets | 1 | 2018 | 50 | 0.030 |
Why?
|
| Medical Audit | 1 | 2018 | 43 | 0.030 |
Why?
|
| Genome, Viral | 1 | 2018 | 83 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2024 | 2551 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 408 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2018 | 131 | 0.030 |
Why?
|
| Hospitals, University | 1 | 2017 | 192 | 0.030 |
Why?
|
| Anti-Infective Agents | 1 | 2017 | 87 | 0.030 |
Why?
|
| Inpatients | 1 | 2020 | 367 | 0.030 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2018 | 132 | 0.030 |
Why?
|
| Seasons | 1 | 2018 | 252 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2017 | 369 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2021 | 731 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2018 | 350 | 0.030 |
Why?
|
| United States | 2 | 2019 | 8262 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2021 | 11043 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2015 | 141 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 578 | 0.030 |
Why?
|
| Biomarkers | 1 | 2021 | 2021 | 0.030 |
Why?
|
| Phylogeny | 1 | 2018 | 1340 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2017 | 2212 | 0.020 |
Why?
|
| Mycobacterium avium Complex | 1 | 2011 | 7 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 3228 | 0.020 |
Why?
|
| Bacterial Typing Techniques | 1 | 2011 | 28 | 0.020 |
Why?
|
| DNA, Ribosomal | 1 | 2011 | 55 | 0.020 |
Why?
|
| Inflammation | 1 | 2017 | 1133 | 0.020 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2011 | 270 | 0.020 |
Why?
|
| Griseofulvin | 1 | 2009 | 1 | 0.020 |
Why?
|
| Trichophyton | 1 | 2009 | 1 | 0.020 |
Why?
|
| Africa, Western | 1 | 2009 | 12 | 0.020 |
Why?
|
| Ketoconazole | 1 | 2009 | 23 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2016 | 1214 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 2009 | 127 | 0.020 |
Why?
|
| Animals | 2 | 2018 | 28981 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 917 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 2897 | 0.020 |
Why?
|
| HIV Infections | 1 | 2016 | 1018 | 0.020 |
Why?
|
| Mutation | 1 | 2018 | 4428 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2016 | 1842 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2011 | 901 | 0.010 |
Why?
|
| Mice | 1 | 2017 | 12735 | 0.010 |
Why?
|